Skip to content

Drug interactions

Dapagliflozin-metformin + Pegvisomant

Severity: Moderate

Dapagliflozin-metformin and Pegvisomant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pegvisomant lowers IGF-1 and growth hormone activity, which improves insulin sensitivity in acromegaly. Patients on antidiabetic drugs may have lower glucose levels and, rarely, hypoglycemia, and labeling advises that doses may need reduction.

What this interaction means in plain words

Dapagliflozin-metformin and Pegvisomant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dapagliflozin-metformin belongs to Endocrine; Pegvisomant belongs to Endocrine.

Evidence level: Moderate

Why it happens

Blockade of growth hormone receptors reduces insulin resistance, adding to glucose lowering.

What to do

Monitor blood glucose after starting pegvisomant and reduce antidiabetic doses if glucose falls.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dapagliflozin-metformin and Pegvisomant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dapagliflozin-metformin with Pegvisomant?

MediHelp rates the interaction as moderate. Dapagliflozin-metformin and Pegvisomant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pegvisomant lowers IGF-1 and growth hormone activity, which improves insulin sensitivity in acromegaly. Patients on antidiabetic drugs may have lower glucose levels and, rarely, hypoglycemia, and labeling advises that doses may need reduction.

How serious is the interaction between Dapagliflozin-metformin and Pegvisomant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose after starting pegvisomant and reduce antidiabetic doses if glucose falls.

What other medicines interact with Dapagliflozin-metformin?

MediHelp also lists interactions of Dapagliflozin-metformin with, for example, Contrast media, Diatrizoate, Diatrizoate meglumine / diatrizoate. The full list is on the Dapagliflozin-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in